You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Colorcon
Dow
Johnson and Johnson
Moodys

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

Patent: 9,370,527

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,370,527
Title:Amelioration of intestinal fibrosis and treatment of Crohn\'s disease
Abstract: Methods of treating patients with inflammatory bowel disease, intestinal fibrosis, or Crohn\'s disease involve administering a therapeutic amount of CARD-024 or related compound.
Inventor(s): Simpson; Robert U. (Ann Arbor, MI), Higgins; Peter D. R. (Ann Arbor, MI), Johnson; Laura A. (Ann Arbor, MI)
Assignee: The Regents Of The University Of Michigan (Ann Arbor, MI)
Application Number:14/134,587
Patent Claims:see list of patent claims

Details for Patent 9,370,527

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24   Start Trial The Regents Of The University Of Michigan (Ann Arbor, MI) 2033-12-19 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Express Scripts
Mallinckrodt
Medtronic
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.